EEMCX
Price
$13.62
Change
-$0.02 (-0.15%)
Updated
Jul 25 closing price
Net Assets
787.84M
VEMAX
Price
$42.20
Change
-$0.14 (-0.33%)
Updated
Jul 25 closing price
Net Assets
124.04B
Interact to see
Advertisement

EEMCX vs VEMAX

Header iconEEMCX vs VEMAX Comparison
Open Charts EEMCX vs VEMAXBanner chart's image
Columbia Emerging Markets C
Price$13.62
Change-$0.02 (-0.15%)
VolumeN/A
Net Assets787.84M
Vanguard Emerging Mkts Stock Idx Adm
Price$42.20
Change-$0.14 (-0.33%)
VolumeN/A
Net Assets124.04B
EEMCX vs VEMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EEMCX vs. VEMAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EEMCX is a StrongBuy and VEMAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 124B vs. EEMCX (788M). VEMAX pays higher dividends than EEMCX: VEMAX (2.76) vs EEMCX (0.32). EEMCX was incepted earlier than VEMAX: EEMCX (18 years) vs VEMAX (19 years). EEMCX (2.29) is less costly to investors than VEMAX (0.13). EEMCX is a more actively managed with annual turnover of: 44.00 vs. VEMAX (8.00). EEMCX has a lower initial minimum investment than VEMAX: EEMCX (2000) vs VEMAX (3000). EEMCX (19.58) and VEMAX (19.11) have marching annual gain over last year. VEMAX return over 5 years is better than : 30.79 vs. EEMCX (1.94).
EEMCXVEMAXEEMCX / VEMAX
Total Expense Ratio2.180.131,677%
Annual Report Gross Expense Ratio2.290.131,762%
Fund Existence18 years19 years-
Gain YTD15.52215.039103%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRA1000N/A-
Net Assets788M124B1%
Annual Yield % from dividends0.322.7612%
Returns for 1 year19.5819.11102%
Returns for 3 years26.0933.8777%
Returns for 5 years1.9430.796%
Returns for 10 years47.9858.4682%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTGX55.151.41
+2.62%
Protagonist Therapeutics
IMTX6.560.11
+1.71%
Immatics NV
DLTH2.31-0.01
-0.43%
Duluth Holdings
TTWO224.75-3.98
-1.74%
Take-Two Interactive Software
BLRX4.25-0.26
-5.76%
BioLineRx Ltd